SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $72,000 | +380.0% | 3,015 | +480.9% | 0.00% | – |
Q3 2019 | $15,000 | -59.5% | 519 | -54.0% | 0.00% | – |
Q2 2019 | $37,000 | -11.9% | 1,129 | -4.6% | 0.00% | – |
Q1 2019 | $42,000 | -10.6% | 1,184 | -16.7% | 0.00% | – |
Q4 2018 | $47,000 | +20.5% | 1,421 | +85.5% | 0.00% | – |
Q3 2018 | $39,000 | -56.7% | 766 | -60.8% | 0.00% | -100.0% |
Q2 2018 | $90,000 | 0.0% | 1,955 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $90,000 | +40.6% | 1,955 | +23.7% | 0.00% | 0.0% |
Q4 2017 | $64,000 | -14.7% | 1,581 | -14.8% | 0.00% | 0.0% |
Q3 2017 | $75,000 | -15.7% | 1,856 | -10.3% | 0.00% | 0.0% |
Q2 2017 | $89,000 | +11.2% | 2,070 | -18.6% | 0.00% | 0.0% |
Q1 2017 | $80,000 | +11.1% | 2,544 | -11.2% | 0.00% | 0.0% |
Q4 2016 | $72,000 | +9.1% | 2,865 | +5.4% | 0.00% | 0.0% |
Q3 2016 | $66,000 | -13.2% | 2,718 | -27.2% | 0.00% | 0.0% |
Q2 2016 | $76,000 | +35.7% | 3,734 | +1.2% | 0.00% | 0.0% |
Q1 2016 | $56,000 | +86.7% | 3,690 | +67.1% | 0.00% | 0.0% |
Q4 2015 | $30,000 | -18.9% | 2,208 | -16.7% | 0.00% | 0.0% |
Q3 2015 | $37,000 | -17.8% | 2,651 | +1.0% | 0.00% | 0.0% |
Q2 2015 | $45,000 | +200.0% | 2,626 | +116.8% | 0.00% | – |
Q1 2015 | $15,000 | +50.0% | 1,211 | 0.0% | 0.00% | – |
Q4 2014 | $10,000 | -9.1% | 1,211 | 0.0% | 0.00% | – |
Q3 2014 | $11,000 | -15.4% | 1,211 | 0.0% | 0.00% | – |
Q2 2014 | $13,000 | +44.4% | 1,211 | +21.1% | 0.00% | – |
Q1 2014 | $9,000 | +12.5% | 1,000 | 0.0% | 0.00% | – |
Q4 2013 | $8,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
Versant Capital Management, Inc | 16 | $463 | 0.00% |